We are experiencing some temporary issues. The market data on this page is currently delayed. Please bear with us as we address this and restore your personalized lists.
Previous Close | 3.0400 |
Open | 3.0500 |
Bid | 3.0300 x 0 |
Ask | 3.0500 x 0 |
Day's Range | 3.0200 - 3.0800 |
52 Week Range | 2.3300 - 4.2800 |
Volume | |
Avg. Volume | 101,071 |
Market Cap | 1.162B |
Beta (5Y Monthly) | 1.02 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.2000 |
Earnings Date | Nov 06, 2024 - Nov 11, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 3.66 |
We came across a bullish thesis on Cronos Group Inc. (CRON) on Raging Bull Investments’ Substack by Jake LaMotta. In this article we will summarize the bulls’ thesis on CRON. Cronos Group Inc. (CRON) share was trading at $2.26 as of Sept 17th. Cronos Group represents a compelling investment opportunity, given its recent financial performance and substantial […]
TORONTO, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) is expanding its portfolio for its Lord Jones® brand with new innovations to bolster its lineup of premium cannabis products in the Canadian market. The additions include new cultivars for the Lord Jones® Ice Water Hash Fusions Pre-Rolls and Live Resin Vapes, which are now available across Canada. Since the brand’s launch in Canada in November 2023, Ice Water Hash Fusions Pre-Rolls
Today announced its 2024 second quarter business results. Net revenue of $27.8 million in Q2 2024 increased ...
TORONTO (AP) — Cronos Group Inc. CRON) on Thursday reported a loss of $8.8 million in its second quarter. On a per-share basis, the Toronto-based company said it had a loss of 2 cents.
Net revenue in Q2 2024 increased by 46% year-over-year to $27.8 million Industry-leading balance sheet with $848 million in cash and cash equivalents Announced expansion of Cronos GrowCo designed to fuel global growth TORONTO, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced its 2024 second quarter business results. “Cronos achieved its highest quarterly net revenue on record in Q2 2024 at $27.8 million, up 46% year-over-y
TORONTO, July 25, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2024 second quarter earnings conference call on Thursday, August 8, 2024 at 8:30 a.m. ET. Cronos’ senior management team will discuss the Company’s financial results and will be available for questions from the investment community after prepared remarks. To attend the conference call or webcast, participants should register online at https://ir.thecronosgroup.com/eve
TORONTO, July 22, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announces that at its Annual Meeting of Shareholders (the “Meeting”) reconvened July 19, 2024, approximately 98.6% of shareholders voting in person or by proxy approved the appointment of Davidson & Company LLP as the Company’s independent auditor for fiscal year 2024 and authorized the Board of Directors of the Company to fix the independent auditor's remuneration. For complete re
Key Insights The considerable ownership by public companies in Cronos Group indicates that they collectively have a...
TORONTO, July 05, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announced today that it will reconvene its 2024 Annual Meeting of Shareholders on Friday, July 19, 2024, at 11:00 a.m. ET. Cronos will be conducting the reconvened meeting in a virtual-only format via live audio webcast. Registered shareholders and duly appointed proxyholders will have an equal opportunity to participate in the reconvened 2024 Annual Meeting online regardless of th
We recently compiled a list of the 8 Best Pot Stocks to Buy. In this article, we are going to take a look at where Cronos Group Inc. (NASDAQ:CRON) stands against the other pot stocks. The history of the cannabis industry is riddled with changes and conflicting legislation. The international media has played an important […]
Symbol | Last Price | Change | % Change |
---|---|---|---|
ACB.TO Aurora Cannabis Inc. | |||
OGI.TO Organigram Holdings Inc. | |||
WEED.TO Canopy Growth Corporation | |||
TRUL.CN Trulieve Cannabis Corp. | |||
TLRY.TO Tilray Brands, Inc. |
Symbol | Last Price | Change | % Change |
---|---|---|---|
OGI.TO Organigram Holdings Inc. | |||
TLRY.TO Tilray Brands, Inc. | |||
ACB.TO Aurora Cannabis Inc. | |||
CURA.TO Curaleaf Holdings, Inc. | |||
WEED.TO Canopy Growth Corporation |
Maintains | CIBC: Outperformer to Outperformer | 2024-05-15 | |
Maintains | B of A Securities: Underperform to Underperform | 2024-04-08 | |
Maintains | B of A Securities: Underperform to Underperform | 2023-12-28 | |
Maintains | Barclays: Equal-Weight to Equal-Weight | 2023-05-15 | |
Initiated | Bernstein: to Market Perform | 2022-11-02 | |
Maintains | Barclays: to Equal-Weight | 2022-09-30 |
111 Peter Street
Suite 300
Toronto, ON M5V 2H1
Canada
416 504 0004
https://www.thecronosgroup.com
Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 356
Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.